StonvexLoading…
StonvexCore line items from J's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-27 | Q4 2025 2025-12-26 | Annual 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $6.99B | $3.29B | $12.03B | $8.88B |
Operating Income | $151.38M | $232.56M | $863.63M | $652.08M |
Net Income | $79.63M | $125.51M | $289.34M | $167.09M |
EPS (Diluted) | $0.79 | $1.12 | $2.38 | $1.46 |
Total Assets | $11.94B | $11.61B | $11.25B | $11.41B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.37B | $1.55B | $1.24B | $1.29B |
Free Cash Flow OCF − CapEx | $-139.96M | $364.94M | $607.47M | $253.96M |
Shares Outstanding | 118.19M | 117.59M | 119.08M | 119.70M |